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Abstract
Using an ovine model of polycystic ovary syndrome (PCOS), (pregnant ewes injected with testosterone propionate (TP)
(100 mg twice weekly) from day (d)62 to d102 of d147 gestation (maternal injection – MI-TP)), we previously reported
female offspring with normal glucose tolerance but hyperinsulinemia. We therefore examined insulin signalling and
pancreatic morphology in these offspring using quantitative (Q) RT-PCR and western blotting. In addition the fetal
pancreatic responses to MI-TP, and androgenic and estrogenic contributions to such responses (direct fetal injection (FI) of
TP (20 mg) or diethylstilbestrol (DES) (20 mg) at d62 and d82 gestation) were assessed at d90 gestation. Fetal plasma was
assayed for insulin, testosterone and estradiol, pancreatic tissue was cultured, and expression of key b-cell developmental
genes was assessed by QRT-PCR. In female d62MI-TP offspring insulin signalling was unaltered but there was a pancreatic
phenotype with increased numbers of b-cells (P,0.05). The fetal pancreas expressed androgen receptors in islets and genes
involved in b-cell development and function (PDX1, IGF1R, INSR and INS) were up-regulated in female fetuses after d62MI-TP
treatment (P,0.05–0.01). In addition the d62MI-TP pancreas showed increased insulin secretion under euglycaemic
conditions (P,0.05) in vitro. The same effects were not seen in the male fetal pancreas or when MI-TP was started at d30,
before the male programming window. As d62MI-TP increased both fetal plasma testosterone (P,0.05) and estradiol
concentrations (P,0.05) we assessed the relative contribution of androgens and estrogens. FI-TP (commencing d62) (not FI-
DES treatment) caused elevated basal insulin secretion in vitro and the genes altered by d62MI-TP treatment were similarly
altered by FI-TP but not FI-DES. In conclusion, androgen over-exposure alters fetal pancreatic development and b-cell
numbers in offspring. These data suggest that that there may be a primary pancreatic phenotype in models of PCOS, and
that there may be a distinct male and female pancreas.
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Introduction
The steroidal milieu of pregnancy may have diverse and
profound effects upon the physiology of the developing fetus, some
of which may persist into adulthood, conferring lifelong health
consequences. Animal models developed to investigate such
legacies of the fetal environment that have clinical implications
have recently focussed upon polycystic ovary syndrome (PCOS).
PCOS is common; some twenty percent of women have
polycystic ovaries, and approximately one third of these have
additional clinical and biochemical features of PCOS [1]. In
addition to ovarian and reproductive hormonal phenotypes,
women with PCOS are at increased risk of altered metabolic
parameters including hyperinsulinemia and the development of
insulin resistance (IR) [2,3].
Despite intense study, there remains a lack of clear
identification of origins and developmental pathways of this
syndrome. Nonetheless, numerous studies indicate that the
prenatal environment may play a fundamental role in the
development of PCOS, subsequently realised in adult life.
Animal models designed to study potential origins of PCOS
have commonly utilized the single intervention of androgen
overexposure during in utero life [4,5] to recreate many of the
symptoms of PCOS in offspring, notably in rodents [6],
monkeys [7] and sheep [8,9,10]. The legacy effects of increased
androgens on female fetuses seen in those models seem to be
recapitulated by experiments of nature in women [11].
As IR is associated with compensatory increased insulin
secretion [3], hyperinsulinemia associated with PCOS is usually
considered a consequence of IR. However, rodent studies provide
evidence that prenatal androgen exposure causes alterations in
pancreatic b-cell glucose sensitivity [6] and our previous work
demonstrated altered adult insulin secretion in animals treated
prenatally with androgens, in the absence of glucose intolerance
[9]. We hypothesized that there may be an underlying primary
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pancreatic alteration that precedes functional pancreatic changes
in response to IR.
Hence in this study we have further examined insulin signalling
at a molecular level in these animals, examined pancreatic a and
b-cell content, and assessed the potential for androgenic-
programming of fetal b-cell function and pancreatic development.
We include male fetal data sets where pertinent to address the
possibility that such steroidal manipulations create a phenotypi-
cally male pancreas in females. Finally, due to potential placental/
maternal metabolism of testosterone, there remains the issue as to
whether or not endpoints measured result from androgenic or
estrogenic stimuli, and to resolve this we have utilised a direct fetal-
treatment model where we directly administered testosterone
propionate (TP) to the fetus and, in terms of key gene expression
changes and in vitro b-cell function, compared effects of this route
of administration with both maternal injection (MI) of TP, and
direct fetal injection (FI) of the potent estradiol agonist diethyl-
stilbesterol (DES).
We hypothesise that prenatal exposure to excess androgens
results in altered female pancreatic b-cell function in fetal life, and
pancreatic function in adult female offspring, with the implication
that pancreatic b-cell dysfunction may be a primary effect of
prenatal androgen overexposure.
Materials and Methods
Ethics Statement
All studies were approved by the UK Home Office (conducted
under approved Project Licence (PIL 60/3744) after review by the
University of Edinburgh Animal Research Ethics Committee.
Animals
Scottish Greyface ewes were fed to achieve comparable body
condition prior to estrous cycle synchronization. After synchro-
nized mating, animals were allocated randomly to two experi-
mental groups. The experimental groups were given twice weekly
injections of TP (100 mg dissolved in vegetable oil) or vehicle
(vegetable oil) from day (d)30 or d62 gestation until d102 gestation
or sacrifice (term is 147 days). Animals carrying to term were
conventionally managed after this treatment period. In all cases
euthanasia was achieved by barbiturate overdose and numbers are
indicated in the figure legends.
Fetal tissue and plasma was collected at d90 gestation. Actual
numbers of fetuses used in each analysis are specified in figure
legends; differences in numbers of fetuses used are attributable to
constraints of tissue available for each analysis. Furthermore, due
to differences in glucose handling between singleton and twin
fetuses during gestation [12], in all analyses only fetuses from twin
pregnancies were analyzed. In the case of animals that carried to
term, no differences in birth weight associated with any treatment
regimen were evident, and offspring were reared and managed
conventionally (weaned at 3 months) until sacrifice (barbiturate
overdose) at 11 months postnatal age, when tissues were recovered
15 min after intravenous glucose (500 mg/ml in 20 ml) bolus
administration.
Due to practical and economic constraints only female offspring
were reared through to adulthood. In the case of direct FI studies
of steroids, anaesthesia was induced by initial sedation (10 mg
Xylazine; i.m., ‘Rompun’, Bayor plc Animal Health Division, UK)
then administration of 2 mg/kg ketamine (i.v., Keteset, Fort
Dodge Animal Health, UK). Under aseptic surgical conditions
fetuses were injected with 200 ml vehicle alone, 20 mg TP, or
20 mg DES dissolved in vehicle oil via. a 20G Quinke spinal
needle (BD Biosciences, UK), via ultrasound guidance at day 62
and 82 of gestation to coincide and replicate via depot injection
the exposure time frame of the d62 MI-TP cohort. Immediately
after completion of this surgical procedure all ewes were
administered prophylactic antibiotics (1 ml/25 kg; Streptacare,
Animalcare Ltd, UK) and the animals were sacrificed on
gestational d90.
Tissue Collection
Two weeks prior to sacrifice the female MI-TP offspring had a
thigh muscle biopsy taken under local anaesthesia (using 2%
Lidocaine) before and 15 min after i.v. glucose administration
(500 mg/ml in 20 ml). This was snap frozen and stored at 280 C
for subsequent protein extraction and western blotting. At sacrifice
pancreatic tissue was collected and fixed in Bouins solution for
24 h, then rinsed, transferred to 70% ethanol and embedded in
paraffin wax for histological analyses. In addition skeletal muscle,
visceral fat from the omentum, and liver biopsies were collected,
snap frozen and stored at 280 C for subsequent molecular
analysis. In the case of pregnant ewes, fetal blood was collected
and fetuses dissected immediately post-sacrifice. The pancreas of
each fetus was removed, and divided into two/three approxi-
mately equal portions. One piece was fixed and processed for
histological analysis as described above, the second piece was
immediately snap frozen and stored at 280 C for subsequent
mRNA extraction, and in a subset of animals the third piece
immediately processed for tissue culture as described below.
Examination of Gene Expression by Quantitative (Q) RT-
PCR
For RNA extraction, frozen adult tissue samples were homog-
enized with 1 ml TRI-reagent (Sigma Aldrich, UK) following the
manufacturer’s instructions and the RNA was dissolved in 20 ml
RNase-free water. Frozen fetal pancreas was homogenised in RLT
buffer (including 2-mercaptoethanol, 1% v/v) (Qiagen, Crawley,
UK) and RNA was extracted using RNeasy minispin columns
following the manufacturer’s protocols, including on-column
DNaseI digestion (Qiagen, Crawley, UK). RNA concentrations
were determined using a NanoDrop 1000 spectrophotometer
(Thermo Fisher Scientific, Loughborough, UK), with gel electro-
phoresis used to monitor quality. Complimentary DNA (cDNA)
was synthesized according to kit manufacturer protocols (Applied
Biosystems, California, USA).
Previously published and validated primer pairs were used
where possible. This included GAPDH and AR [9] and PDX1,
IGF1, IGF2, IGFR1, IGFR2, SLC2A2 (GLUT2) and INSR [13].
Ovine INS primers were designed and validated by Primer design
Ltd (fwd: CCAGCGGGAAATCAAGAGAGA, rev: CCTAGG-
GAGCTGGTCACTT). Otherwise primers were designed (Prim-
er3 version 0.4) and checked for specificity using Basic Local
Alignment Search Tool (BLAST). Primers were synthesized
(Eurofins MWG Operon, Ebersberg, Germany) and validated as
previously described [9,10]. These primer pairs included: IRS1
(fwd: ATCATCAACCCCATCAGACG, rev: GAGTTTGC-
CACTACCGCTCT), SLC2A1 (GLUT1) (fwd: TGCTGAGCGT-
CATCTTCATC, rev: GGCTCTCCTCCTTCATCTCC),
SLC2A4 (GLUT4) (fwd: ACCTTATGGCCACTCCTCCT, rev:
CTCAGCCAACACCTCAGACA) and LEP (fwd: ATC TCA
CAC ACG CAG TCC GT, rev CCA GCA GGT GGA GAA
GGT C). Gene expression in adult tissues was investigated using a
previously described protocol [14]. Data was normalized and
derived as previously described using GAPDH as a reference gene
[9,10].
For fetal pancreas samples SYBR Green QRT-PCR was
prepared with Sensimix (Bioline UK), primer pairs (0.5 mM),
Effect of Prenatal Androgens on the Pancreas
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e56263
cDNA (1 ml) and nuclease free water. Reactions were carried out
in triplicate using a StepOne Plus platform (Applied Biosystems,
UK). Melting curve analysis revealed a single amplicon in all cases.
Gene expression relative to GAPDH was quantified using the 2-
DDCt method in the case of MI experimental samples after
identification of GAPDH as a stable housekeeping gene (Genorm
analysis (Primer Design Ltd) of 12 ovine reference genes).
However, in the case of FI samples, which encompassed FI-
vehicle, FI-TP and FI-DES treatments, Genorm analysis (Primer-
Design Ltd, UK) revealed that an additional two housekeeping
genes were required to give robust housekeeping stability, hence
the geometric mean of GAPDH, ATP5B and ACTB was used as the
normalization reference. Ovine placenta was used as a positive
control, and negative controls consisted of an RT-ve and a
template negative reaction.
Western Blotting
In the case of western blotting studies, five samples were selected
randomly from each group of 11-month old females (MI-TP
exposed). Protein extraction and pre-clearing was based upon
previously published protocols [15]. Protein content was assayed
(Bio-Rad, Hemel Hempstead, UK) and, after heat denaturation,
samples (10 mg total protein) underwent electrophoresis (5% stack/
12% polyacrylamide resolving) and blotting onto Hybond–P
membranes (GE Healthcare, UK) following the manufacturer’s
protocols. Membranes were blocked in 5% defatted milk solution
in Tris Buffered Saline (TBS)/0.1% Tween (TBST) for 1 h at
room temperature, then probed with primary antibodies raised
against total ERK1/2, phospho-ERK1/2 (Thr202/Tyr204), total
AKT, phospho-AKT (Ser473) (Cell Signalling Technologies Inc.
USA) and b-actin (Sigma Aldrich, UK).
After washing the secondary antibody (chicken anti-rabbit
peroxidise; Santa Cruz Biotechnology Inc. California USA),
diluted 1:2000 in 1% milk/TBST was applied for 1 h before
washing, application of ECL Plus Western Blot Detection System
(GE Healthcare, UK) and exposure to X-ray Film (Super RX
Film, FujiFilm Medical Systems UK). Images were then quantified
by densitometry (GS-700, Bio-Rad Laboratories Ltd, Hertford-
shire, UK) and normalized optical density measured using a-
tubulin as the loading control (Image J Image Processing and
Analysis in Java software (http://rsbweb.nih.gov/ij/)). The ratio of
phosphorylated protein to total protein was then calculated.
Fetal Pancreatic Tissue Culture
Pancreatic tissue was dissected under aseptic conditions and
resuspended in HEPES buffered saline solution (HBSS) containing
3 mg/ml collagenase (Sigma Aldrich, Poole, UK), and incubated
for 20 min at 37C with gentle agitation. After passing through a
19G needle 3 times, cell suspensions were centrifuged (600 g,
10 min, room temperature) and the collagenase solution replaced
with 2 ml HBSS, and the centrifugation step repeated, prior to
resuspension in 1 ml culture medium (Dulbecco’s Modified Eagle
Medium (DMEM), 2 mM L-glutamine, 100 U/ml penicillin,
0.1 mg/ml streptomycin, 0.25% bovine serum albumin (BSA),
pH 7.4 (final glucose concentration 5.5 mM) (Sigma-Aldrich).
Aliquots (100 ml) of cell suspension were added to 300 ml of
culture medium plus treatments (basal glucose/euglycaemic
(5.5 mM), high glucose/hyperglycaemic (20 mM) and incubated
for 3 h, with gentle agitation, at 37C, 5% CO2, in sterile tubes
with vented lids. At the end of the incubation period tubes were
centrifuged (600 g, 15 min), and supernatants removed and frozen
at 220C until insulin measurement. Cell pellets were resuspended
and washed twice in 1 ml PBS, pH 7.4 then re-pelleted by
centrifugation and stored at 220C until protein determination.
Pancreatic cell pellets were resuspended in lysis solution
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Triton-X-100)
and sonicated for 2 min, followed by one minute incubation on
ice, then a further 2 min sonication on ice. Protein was measured
as described above. In pilot experiments glucose treatments were
replicated using mannitol as a glucose substitute to ensure effects of
glucose were specific and not due to osmotic change. Mannitol
(20 mM) did not alter insulin secretion. In the case of FI tissue only
basal (5.5 mM) glucose was examined.
Hormone Determinations
Insulin in tissue culture supernatants and plasma samples was
measured using ELISA kits for ovine insulin (ALPCO, Salem,
NH). Data were collected using a Dynex Technologies Revelation
4.25 plate reader (dual wavelength detection) utilizing cubic spline
curve fit and detection wavelength of 450 nm and a reference
wavelength of 630 nm as per manufacturer’s instructions. All
samples were assayed in duplicate, and on a single plate per
experiment, with an intra-assay coefficient of variation of 4.5%
and sensitivity of 0.14 ng/ml.
Steroid assays were performed on solvent–extracted plasma
samples. Briefly, 100 ml serum for testosterone, and 200 ml serum
in the case of estradiol assays was mixed with 2 ml diethyl ether
(VWR International) and vortexed for 3 min. Solvent and aqueous
phases were separated via freezing, and the solvent phase
evaporated. Tubes containing the dried extract were re-constituted
in phosphate gelatine buffer saline (PGBS) assay buffer. Testos-
terone measurement was performed in duplicate using a standard
in-house radioimmunoassay [9,16], where the intra-assay coeffi-
cient of variation was ,10%, and assay sensitivity 12 pg/ml.
Estradiol concentrations were measured using the MAIA Oestra-
diol ELISA Kit (37001, Inverness Medical UK, Cheshire, UK) as
per the manufacturer’s instructions as described previously [9],
where the intra and inter-CVs were 6% and 9%, respectively and
assay sensitivity was 0.3 pg/ml.
Immunohistochemistry
Tissue sections (5 mm) were mounted onto positively charged
slides (Superfrost Plus Gold, ThermoScientific, Epsom, UK) and
dried overnight at 40C. After clearing in xylene and rehydration
through graded alcohols, antigen retrieval was performed by
microwaving (750W) for 5 min three times in 0.1 M sodium
citrate buffer, pH 6.0, with 1 min between each heating step and
20 min rest period at the end of this process. Slides were then
incubated in 3% H2O2 followed by two further 5 min washes in
PBS. After blocking with 2.5% horse serum (Vector laboratories,
Peterborough, UK), the sections were incubated with primary
mouse anti-insulin monoclonal antibody (Abcam, Cambridge,
UK) at a dilution of 1 in 500 (10 mg/ml), primary rabbit anti-
glucagon antiserum (Millipore UK) (1 in 500 dilution) or rabbit
anti-AR antiserum (1 in 50 dilution) (Santa Cruz, Santa Cruz,
CA), overnight at 4C. Negative controls consisted of mouse IgG or
non-immune rabbit serum at an identical concentration to that of
the primary antiserum.
Slides were then washed twice for 5 min in PBS containing
0.1% Tween-20 (PBST) and treated with biotin-conjugated
secondary antibody (pan-specific anti-mouse and rabbit, Vector
laboratories) for 30 min. After two further washes in PBST, ABC
complex (Vector laboratories) was applied to sections for 30 min.
After a further two washes in PBST 3,3-diaminobenzidine (Vector
laboratories) was used to visualize bound antibody. The slides were
then washed, counterstained in haematoxylin (Sigma-Aldrich),
dehydrated, cleared in xylene and mounted in Pertex (Vector
laboratories). Initial pilot studies were conducted to determine
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numbers of sections and fields of observation to give accurate,
representative mean counts per sample. As a result of this pilot
analysis, three sections of each fetal tissue, and five sections per
adult tissue, in both cases cut 100 mm apart, were quantified.
Slides were digitally captured using Spot32 (Diagnostic Instru-
ments Inc., Sterling Heights, MI, USA). To determine b-cell
number, five random fields were examined in each section using
an eyepiece grid, all positively stained cells counted and results
were expressed as numbers of b-cells per mm2. In adult tissue islet
size was determined via a calibrated eye-piece grid, measuring the
area of 10 islets per section, in 5 sections per animal.
In studies of co-localization of AR and insulin, sections were
processed as described above prior to being incubated with AR-
specific antibody (Santa Cruz, Santa Cruz, CA) at a concentration
of 1 in 50 in 2.5% goat serum overnight at 4C. After washing, the
sections were incubated with fluorescently labelled secondary
antibody (Alexafluor 633, goat-anti-rabbit) at a concentration of 1
in 200 in PBS, pH 7.4, for 30 min and washed twice in PBST and
once in PBS. Sections were then re-blocked in 2.5% goat serum
and incubated with insulin antiserum at a concentration of 1 in
500 overnight at 4C. After washing, the sections were incubated
with labelled secondary antibody (Alexafluor 488, goat-anti-
mouse) at a concentration of 1 in 200, for 30 min. After washing,
the sections were mounted in Mowoil (Calbiochem, Nottingham,
UK), stored overnight at 4C and visualized using a Zeiss LSM 500
Meta system confocal microscope. Negative controls were as
described for conventional immunohistochemistry.
Statistical Analysis
Statistical analyses were performed with Graph Pad Prism v4.0
(GraphPad Software Inc., San Diego, CA) and values of P,0.05
regarded as significant. Student’s t-test (where applicable) and one-
way ANOVA with Tukey’s post hoc testing was applied. Where
data showed a non-normal distribution log (base10) transforma-
tion was applied prior to analysis.
Results
Peripheral Insulin Signalling in 11 Month Old Female
Offspring from d62MI-TP Experimental Pregnancies
As regards mRNA expression of key genes involved in insulin
signalling, in utero d62MI-TP exposure had no significant effects in
either muscle (Fig. 1A), liver (Fig. 1B) or visceral fat (Fig. 1C).
Analyses of downstream insulin receptor signalling in skeletal
muscle biopsies before and after glucose administration (Fig. 1D,
representative blot)), or at sacrifice after a glucose bolus (Fig. 1F,
representative blot), showed no alterations between in utero vehicle
treated and d62MI-TP exposed animals in terms of total :
phosphorylated ERK or AKT ratios (Fig. 1E, G quantified blots).
Pancreatic Morphology of 11 Month Old Adult Offspring
from MI-TP Experimental Pregnancies
We therefore assessed the effect of MI-TP treatment from d62
gestation on the morphology of the endocrine pancreas in terms of
the numbers of a and b-cells. There was a significant increase in
the total number of b-cells in prenatally d62 MI-TP-treated
animals (P,0.05) (Fig. 2). Whilst there was no significant
difference in islet size, there was a trend towards increased islet
size (P= 0.07) (not shown), and a significant increase in the
numbers of b-cells per islet (P,0.01) (Fig. 2). This was not
associated with any change in the numbers of a-cells in the
pancreatic islets (Fig. 2).
Effects of d62 MI-TP Treatment on Fetal Pancreatic
Morphology
As these data suggested that maternal TP exposure in
pregnancy results in an early pancreatic phenotype we assessed
the fetal pancreas at the time of maternal androgenization.
However, as the endocrine pancreas represents only a small
percentage of total pancreatic tissue, and due to the difficulties
associated with dissection of fetal pancreatic tissue, pancreatic
weight is not a reliable measure [17] and as such we initially
focused on immunohistochemical assessment of the developing
fetal pancreas at d90 gestation. Androgen receptors were
immunolocalized to multiple cell types in the fetal pancreas before
d90 gestation (Fig. 3Ai). Dual-fluorescent immunohistochemistry
confirmed that b-cells express AR by co-localizing AR and insulin
in the same tissue sections (Fig. 3Aii–vi). This highlights that the
fetal pancreatic cells with the potential to directly respond to
androgens included the insulin secreting islet b-cells. However,
there was no significant difference in the expression of AR (Fig. 3B)
or the number of insulin-positive b-cells at d90 (Figure 3C) of
gestation between tissues from female fetuses after maternal
exposure to TP when compared to vehicle controls.
Effects of Androgens on the Expression of Key Fetal
Pancreatic Genes in vivo
We next investigated the expression of pancreatic genes
pertinent to b-cell replication and function (Fig. 4). In female
fetuses at d90 of gestation, d62 MI-TP administration did not
significantly alter expression of IGF1, IGF2, IGF2R or SLC2A2
(Fig. 4). However in female fetuses pancreatic expression of IGF1R
(P,0.05), INSR (P,0.05), PDX1 (P,0.01) and INS (P,0.05) were
up-regulated by maternal TP administration from d62 (Fig. 4). Of
particular interest was that maternal androgen treatment had no
effect on the expression of these candidate genes in male fetuses.
Furthermore there were differences in pancreatic gene expression
between the control female and control male tissues (Fig. 4). Both
pancreatic IGF1 (P,0.01) and SLC2A2 (P,0.001) had significantly
higher levels of expression in female fetuses than that observed in
male fetuses (Fig. 4).
Effects of Maternal Androgenization from d30 on Fetal
Pancreatic Gene Expression
We then studied the effect of earlier androgenization on the
expression of key developmental genes in the fetal pancreas. The
effects of maternal androgens administered from d30 gestation
(d30MI-TP), which is before the sex determination window and
results in masculinization of the external genitalia, are shown in
Table 1. D30 MI-TP administration had no apparent effects on
any gene measured in female fetuses apart from IGF1R expression
that was elevated in a similar fashion to that observed in the d62
treated cohort (Table 1).
Effects on Androgen on Fetal Pancreatic Endocrine
Function
Unfortunately we did not measure fetal glucose concentrations
to allow full assessment of pancreatic function in vivo. There were
no significant differences in fetal plasma insulin concentrations
after maternal androgenisation (Table 2). However we were able
to assess the functional consequences of maternal androgen
administration on the endocrine function of the female fetal
pancreas in vitro. Pancreatic tissue from vehicle and d62MI-TP
groups was enzymatically digested and cultured in the presence of
5.5 mM and 20 mM glucose (Table 2). Although pancreatic tissue
from both experimental groups secreted insulin only tissue from
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control fetuses was capable of mounting a significant increase in
insulin secretion in response to 20 mM glucose (P,0.05 compared
to 5.5 mM glucose). When exposed to 5.5 mM glucose, pancreatic
tissue from MI-TP female fetuses had a comparable insulin
response to that of vehicle treated tissue cultured in the presence of
20 mM glucose, thus giving rise to a significantly reduced glucose
stimulation index (SI) [18] when compared to control tissue.
Maternal Androgen Treatment also Increases Fetal
Estradiol Concentrations
Maternal d62 MI-TP administration raised fetal female
testosterone concentrations at d90 to that seen in male fetuses
(P,0.05; Fig. 5A). However the placenta can aromatize androgen
to estrogen and fetal estradiol concentrations were also signifi-
cantly (P,0.05) greater than vehicle treated female fetuses after
maternal androgenisation (Fig. 5B).
Pancreatic Effects of Direct Injection of Androgens and
Estrogens into the Fetus
To dissect the effects of androgens and estrogens we directly
injected either TP, DES or vehicle into the fetus at d62 and d82 of
gestation and analysed the effects at d90 gestation. Pancreatic
genes whose expression was altered in female fetuses at d90 after
d62 MI-TP treatment were examined after direct fetal treatment.
We found that FI-TP, but not FI-DES administration, caused
significant increases in the expression of INS (P,0.05), PDX1
(P,0.05), INSR (P,0.01), and a strong trend in the case of IGF1R
(P= 0.06) (Fig. 6A). In addition in vitro cultures of tissue recovered
from the pancreas of fetal sheep directly injected with either TP or
DES showed an increased secretion of insulin in direct response to
FI-TP, but no difference as compared to control cultures in the
case of DES, in response to a fixed, euglycaemic concentration
(5.5 mM) of glucose (P,0.05) (Fig. 6B).
Discussion
Maternal administration of exogenous androgens during
pregnancy perturbs reproductive and metabolic function of
offspring in various species during adult life, the clinical relevance
being that this adult physiology, in both reproductive and
metabolic aspects, is reminiscent of PCOS in women
[4,6,9,10,19]. PCOS encompasses metabolic abnormalities such
as IR and, as a downstream consequence, hyperinsulinemia in
Figure 1. Molecular determination of skeletal muscle and hepatic insulin signalling in d62MI-TP 11 month old female offspring.
Gene expression (Panels A–C, vehicle treated n= 5; TP treated n= 9) and protein phosphorylation (Panels D and F vehicle treated n= 5; TP treated
n= 5) and its quantification (Panels E and G) relevant to insulin signalling in muscle, liver and visceral fat was analyzed in early adult female offspring
from MI-TP pregnancies. No significant alterations in expression of key insulin signalling and reception genes were evident in either tissue associated
with prenatal treatment. Panel D shows representative western blots of insulin signalling proteins (MAPK and AKT pathways) in muscle biopsies
before and after glucose bolus and Panel F shows these pathways in muscle at sacrifice two weeks later after glucose bolus from the aforementioned
pregnancies. Quantified data from these western blots in shown in Panels E and G – there were no differences in ratios of total : phosphorylated ERK
or AKT associated with prenatal treatment.
doi:10.1371/journal.pone.0056263.g001
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women [2,5], which are recreated by in utero overexposure to
androgens in animal models.
In studies of both in utero androgen overexposure animal models,
and human PCOS, there are intriguing indications of pancreatic
b-cell dysfunction [3,20], and suggestions that the causal
relationship between hyperinsulinaemia and IR, at least in lean
women with PCOS, is weaker than perhaps commonly assumed
[21]. In a previous study [9] we observed that prenatal
androgenization via maternal administration of TP commencing
at day 62 of gestation gave rise to offspring that exhibited early
hyperinsulinemia, raising the question as to whether or not IR
underpinned increased insulin secretion, or there was a primary
pancreatic alteration.
Examination of the possibility of pancreatic changes occurring
in response to an altered in utero steroid milieu is pertinent in
light of findings that the pancreas is a sex-steroid responsive
tissue [6,22,23], and observations of altered b-cell function in
early postnatal life in a mouse model of in utero androgenic
exposure [6]. Studies utilizing primate androgen exposure
models also are suggestive of b-cell alterations, evident in early
post-natal life in terms of increased insulin secretion in response
to glucose challenge. Whilst the explanation for this was
persistence of a fetal response to maternal hyperglycaemia [7],
programming effects of androgens directly on the pancreas may
also be possible.
Analysis of gene expression and protein phosphorylation
relevant to insulin signalling in target tissues was undertaken to
assess if we could detect molecular peripheral insulin resistance in
the MI-TP offspring sheep that demonstrate an increased insulin
response to glucose [9]. This is in light of reports of altered insulin
signalling in PCOS, via altered Ras-ERK activity [15], and
elevated Akt-mediated insulin signalling, associated with IR and
hyperinsulinaemia [24]. We detected no alterations in insulin
signalling at the molecular level in the target tissues we analyzed.
This, with the early hyperinsulinemia [9] raised the possibility of
primary pancreatic alterations as a consequence of prenatal
Figure 2. The effect of TP administration on adult endocrine pancreas. Female adult a- and b-cell content from vehicle and MI-TP treated
pregnancies was assessed by immunohistochemistry. Prenatal TP treatment was associated with significantly increased total b-cell numbers at 11
months postnatal age in MI-TP offspring (n = 8) (P,0.05), which in turn was associated with increased numbers of b-cells per islet (P,0.01), as
compared to vehicle treated offspring (n = 5). There were no effects of prenatal treatment as regards a-cell content. Photomicrographs are
representative sections of adult pancreas from vehicle and MI-TP treated pregnancies (scale bars represent 50 mm).
doi:10.1371/journal.pone.0056263.g002
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androgen overexposure. In a similar ovine model where androgen
exposure began at d30, hyperinsulinemia in offspring was
observed, but could not be definitively ascribed to IR [25].
It should be noted that the majority of previous studies of the
ovine adult phenotype created by prenatal androgenization
commenced maternal androgen treatment at d30 gestation
[25,26,27] and the PCOS-like changes [28,29] that occur after
starting later have been less well studied. However commencement
of TP administration at d62 means that female offspring develop
normal external female genitalia while displaying alterations in
ovarian follicular gene expression commensurate with alterations
in thecal steroidogenesis found in women with PCOS [10] and
early metabolic imbalance with hyperinsulinemia [9]. Interesting-
ly, studies in primate models showed that earlier gestation
androgen excess was possibly associated with impaired b-cell
function [30], indicative that timing of exposure and cross-species
comparisons must be carefully considered.
Examination of pancreatic tissue from 11 month old adult
offspring from our d62 MI-TP androgen overexposed pregnancies
revealed increased b-cell numbers, and increased numbers of b-
cells per islet, suggesting that fetal androgen overexposure may
have had direct effects that persisted into post-natal life. In women
with PCOS it has been suggested that b-cell dysfunction is
permanent [31], and rodent models show differential responses to
elevated glucose at 3–6 months postnatal age from androgen
treated pregnancies [6]. We detected no alteration in the islet a-
cell content of these adult pancreases, and in this regard it is
pertinent to note that studies of effects of maternal nutrition on
pancreatic development in sheep fetuses reveal plasticity of b-cell
development, but not a-cell development [32]. We therefore
focussed attention on examining fetal pancreatic b-cell responses
to over-exposure to androgens.
Ovine fetal pancreatic b-cells expressed androgen receptors,
suggesting androgen responsiveness. AR immunoreactivity was
also noted in non-insulin positive cells in pancreatic islets, in line
with previous work in the mouse pancreas where islet cells per se
expressed AR [23], indicative that androgens may exert effects on
other endocrine cells of the pancreas.
We observed no alterations in fetal plasma insulin due to
treatment (or fetal sex), but this is coloured by glucose
concentrations and clearance, such that it is to a large extent
maternal/placental regulated, and therefore it is not straightfor-
ward to ascribe fetal plasma concentrations of insulin directly to
fetal b-cell function/secretory capacity. However, when fetal
pancreatic tissue was challenged in vitro by elevating glucose
concentrations from 5.5 mM (normal pregnant ewe glucose is
approximately 3–5 mM, [33]) to 20 mM, pancreatic tissue derived
from androgen-exposed female fetuses did not mount an insulin
response whereas tissue from vehicle-treated female fetuses
demonstrated the expected rise in insulin secretion. Interestingly,
in vitro insulin secretion was higher in response to 5.5 mM glucose
in TP-exposed female tissue than in female controls, comparable
to the insulin output realised by 20 mM glucose in female tissue
and subsequently in vitro SI was reduced by TP treatment.
Prenatally androgenized mouse islets show impaired glucose
sensing, and secreted approximately twice the amount of insulin
Figure 3. Ovine fetal pancreatic androgen receptor localization, AR expression and b-cell content. Panel A: (i) Fetal pancreas showing
nuclear AR protein (brown) in multiple cell types including glandular tissue (black arrows) and presumed islets (red arrows). (ii) Fluorescent
immunohistochemical staining for insulin (green) in a (vehicle) d90 fetal pancreas. (iii) Fluorescent immunohistochemical staining for AR (red) in a
(vehicle) d90 fetal pancreas and (iv) represents a dual merge of insulin (green) and AR (red) confirming that b-cells express AR. (v) and (vi) show
negative controls for insulin and androgen receptor respectively. Scale bar is 100 mm (i) and 25 mm (ii–vi). MI-TP had no effect on either AR
abundance (n = 5, n = 8, vehicle and TP fetuses respectively) (Panel B) or fetal b-cell numbers (Panel C).
doi:10.1371/journal.pone.0056263.g003
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Figure 4. Fetal pancreatic expression of key developmental genes and in vitro insulin secretion is dependent upon fetal sex and
timing of exposure to excess androgens. A: Female fetuses: At d90, (vehicle n= 5, MI-TP n = 8), d62 MI-TP significantly increased expression of
IGF1R (P,0.05), PDX1 (P,0.01), INSR (P,0.05) and INS (P,0.05) mRNA. Male fetuses: Whilst there were differences in expression attributable to the
sex of the fetuses (see results section for full description), there were no differences in expression of any genes studied attributable to in utero
treatment in male fetuses studied at d90 (vehicle n = 6, MI-TP n = 6) of gestation. Different superscripts denote significant differences (P,0.01–0.05,
see results sections for full details).
doi:10.1371/journal.pone.0056263.g004
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that control islets secreted in response to moderate, euglycaemic
glucose concentrations [6], consistent with our observations in the
ovine model.
The pancreas of PCOS patients with a family history of type 2
diabetes mellitus (T2DM) has a somewhat limited capacity for
increased insulin secretory response to glucose [34]. This has also
been observed in obese adolescents with PCOS, suggesting greater
risk of T2DM development when inherent b-cell impairment, in
terms of plasticity of insulin secretion, is coupled with IR [20], and
more recent studies also suggest possible alterations in b-cell
responsiveness to IR associated with PCOS [35].
Women with PCOS have greater insulin secretion in response
to IR than women with similar IR but no PCOS [3]. Furthermore,
it has also been determined that whilst weight reduction in PCOS
has a favourable outcome in terms of reduction of insulin
resistance, hyperinsulinemia was not reduced to the same degree
[36]. Given correlations between insulin secretion and bioavailable
testosterone [3], a primary pancreatic defect tipping the balance
towards over-secretion of insulin may be an important factor in the
development and progression of PCOS.
In order to examine potential mechanisms underpinning altered
b-cell function in response to prenatal androgenization, pancreatic
expression of genes with critical roles in fetal islet development and
b-cell function were examined at d90 of gestation. Local
expression of genes which play regulatory roles in both b-cell
development and function, such as IGF1 and IGF2, were
unaffected by d62 MI-TP treatment in female fetuses while IGF1R
increased. Although not b-cell specific, given the important role of
IGF signalling in islet development and b-cell function [13,37],
and the similar elevated expression response to MI-TP in terms of
INSR, it is likely that IGF and insulin signalling are potential
mediators of androgen action in the pancreas. It is also noteworthy
that female offspring from d62 MI-TP pregnancies had increased
hepatic expression of IGF-1 [9].
INS expression was also elevated in response to d62 MI-TP and
it was accompanied by a functional effect in the form of the
aforementioned increased in vitro basal insulin secretion. This
represents a b-cell specific effect of d62 MI-TP on the pancreas of
female fetuses. Testosterone has been previously shown to increase
INS expression [38] and be anti-apoptotic in male rat islets in vitro
[39] although there are reports of sex-specific differences in such
androgen responses [40]. A second b-cell specific gene expression
alteration in response to treatment was observed in terms of PDX1,
whose expression was significantly increased by d62 MI-TP
administration.
Given the presence of AR in b-cells, and elevated testosterone
concentrations in MI-TP female fetuses, these effects are likely to
be due to a combination of direct androgenic stimulation of b-
cells, and/or indirect effects mediated via increased growth factor
receptor expression. IGF/insulin signalling can regulate b-cell
mass upstream of PDX1 [41] as evidenced by reductions in IGF/
insulin signalling being associated with decreased PDX1 expression
[37]. Mechanistically, islet hyperplasia and apoptotic protection
has been linked to increased IGF2 signalling in rodents [17,42].
IGF-signalling (specifically IGF2) is thought to be anti-apoptotic in
b-cells (acting through IGF1R; [13]) and is suggested to prevent
the post-natal wave of b-cell apoptosis in rodents [43].
In addition to its role in b-cell mass regulation [13], PDX1 also
appears to play a role in glucose-driven INS expression [44], hence
there is likely a functional relationship between increased IGF1R,
PDX1 and INS expression and increased in vitro secretion of insulin,
in the d62 MI-TP female fetuses at d90. Whilst it has been
suggested that glucocorticoids have a regulatory role in PDX1
expression [45], to our knowledge this is the first time that
androgenic regulation, either direct or indirect, has been observed.
Regarding the potential for long-term consequences of such
gene expression alterations in fetal life, fetal growth restriction
Table 1. Summary comparison of mRNA responses in female
fetuses exposed to TP from d60 compared to female fetuses
exposed to TP from d30 of gestation.
Female Female
D62–90 D30–90
Gene Vehicle vs TP Vehicle vs TP
INSR 0.7860.11 vs 1.0960.08* 0.5860.08 vs 0.7260.09
INS 1.1360.35 vs 1.7660.26* 1.3660.21 vs 1.4960.10
PDX1 0.9460.17 vs 1.5060.08** 1.0160.13 vs 1.2960.05
IGF1R 0.6560.17 vs 1.0860.11* 0.4660.03 vs 0.8160.14*
D30 MI-TP (n = 6 vehicle, n = 6 TP) caused increased IGF1R expression in a
similar fashion to that observed in female fetuses exposed to MI-TP from d62,
but in the case of the other genes measured, there was no response to
treatment from d30 in female fetuses, similar to the lack of response observed
in d62 MI-TP male fetuses (see Figure 4). Asterisks denote significant difference
between vehicle and TP treated *P,0.05;
**P,0.01.
doi:10.1371/journal.pone.0056263.t001
Table 2. In vitro glucose stimulated insulin secretion and plasma insulin from vehicle and d62 MI-TP fetuses at d90 gestation.
Female fetuses Vehicle (in vivo) D62–D90 TP (in vivo)
In vitro Insulin secreted Insulin secreted
ng/mg tissue (SI) ng/mg tissue (SI) Significance
Basal (5.5 mM glucose) 0.460.03 (1.7560.16) 1.3060.32 (0.8960.19#) P,0.05
Maximal (20 mM glucose) 0.7160.1* 1.2260.42 P,0.05
In vivo Plasma Insulin ng/ml Plasma insulin ng/ml
0.8360.19 0.4860.07 P.0.05
There was no effect of d62 MT-TP on insulin concentrations (d90 female vehicle n = 6, MI-TP n= 8). Pancreatic tissue was collected from control and MI-TP-exposed
female fetuses, enzymatically dispersed and cultured in vitro. Only tissue from vehicle treated pregnancies was able to mount the expected increase in insulin secretion
(*P,0.05) in response to elevated (20 mM) glucose in vitro. Under euglycaemic glucose concentrations (5.5 mM), in vivo MI-TP-exposure lead to a significantly reduced
SI (#P,0.05) in female fetuses, however, basal insulin secretion from MI-TP fetal pancreatic tissue was significantly elevated as compared to tissue derived from vehicle
treated fetuses (P,0.05), and comparable to maximal secretion of vehicle treated tissue stimulated by 20 mM glucose.
doi:10.1371/journal.pone.0056263.t002
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(FGR) in rodents permanently reduces PDX1 in b-cells via altered
gene methylation, culminating in adult diabetes (reviewed by [37]).
In sheep, FGR is associated with altered b-cell function
postnatally, and altered pancreatic expression of INSR and IGF2
[13]. Collectively, these findings indicate that pancreatic expres-
sion/function of local and intrinsic regulators of b-cell replication
and function can be permanently affected during in utero life, with
consequences for adult health. Given the role of PDX1 in b-cell
replication, and elevated fetal INS expression, these alterations in
expression in response to d62 MI-TP may therefore represent fetal
antecedents of the increased b-cell numbers and hyperinsulinemia
observed in offspring from MI-TP manipulated pregnancies.
An overarching finding of the gene expression analysis
undertaken was that MI-TP treatment, commencing at d62 of
gestation, does not appear to cause development of a phenotyp-
ically ‘male’ pancreas in a female fetus, in terms of either
pancreatic gene expression responses (INS, PDX1, IGF1R and
INSR) to exogenous androgen exposure, or endogenous SLC2A2
expression. In other genes examined in the d62 model there were
no sex-specific differences in expression in vehicle treated samples;
MI-TP effects, where evident in female fetuses, bore no apparent
relationships to male expression patterns. MI-TP (d62) had no
effects on male pancreatic gene expression measured at d90. Thus
there remains the possibility that this lack of response is at least
partially attributable to pre-exposure of the developing male
pancreas to endogenous testicular androgens from commencement
of testicular steroid production at d30–35 of gestation [46,47].
It may therefore be hypothesized that this earlier exposure may
drive the ‘default pancreas’ towards a ‘male’ phenotype. To
address this possibility we performed an experiment where
androgen exposure (MI-TP) was commenced at d30 in female
fetuses to coincide with the onset of testicular steroidogenesis in
males. Whilst IGF1R was similarly elevated in response to TP
administration at either d30 or d62 of gestation in female fetuses, it
was noted that b-cell associated gene expression, measured at d90,
showed no response, or a muted, non-significant response, to TP
administration when TP exposure began at this earlier d30 stage
as compared to d62, mirroring the lack of response observed in
d62 MI-TP male fetuses. This suggests that during sexual
differentiation, future pancreatic sensitivity to androgenic steroids
may be differentially set in males and females. Thus, females
derived from pregnancies where androgen exposure commenced
at d62 show the response of a female fetus to exogenous androgen
exposure, whereas ovine models commencing androgen treatment
at d30 may give rise to female animals which appear to be
phenotypically male in terms of b-cell response to androgen
exposure. This observation highlights how both early and mid-
gestational TP exposure models can be utilized collectively to tease
apart the effects of timing of androgen exposure during gestation,
and identifies a window, in terms of downstream pancreatic
response to androgen overexposure, of pancreatic sensitivity to
androgens between d30 and d62 of gestation.
Female children whose mothers suffer from PCOS have
elevated umbilical vein testosterone concentrations similar to
concentrations observed for male babies at birth [48]. Fetal
androgen concentrations in our d60 MI-TP treated female fetuses
sheep were, at d90, within a range previously observed in male
sheep fetuses [49] and were comparable to those observed in male
Figure 5. Fetal plasma sex steroid concentrations. In female fetuses, d62 MI-TP administration increased testosterone concentrations
significantly, up to levels similar to that found in male fetuses (d90 vehicle vs TP, P,0.01). Female plasma estradiol was significantly increased by d62
MI-TP treatment at d90 gestation (P,0.05) beyond that of male fetal plasma (d90 female vehicle n= 6, MI-TP n = 8; male vehicle n = 10).
doi:10.1371/journal.pone.0056263.g005
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fetuses in the current study. Thus the androgen-exposure regimen
achieved over-exposure of female fetuses to testosterone in both a
physiological, and human PCOS-relevant context.
Of additional interest was the increased concentration of
estradiol observed in female fetuses at d90 in response to d62
MI-TP. Expression of estrogen receptors a and b in pancreatic b-
cells has been reported and associated, via ERa [50], with
Figure 6. Comparison of direct, fetal administration of TP and DES: effects on pancreatic gene expression, b-cell counts and in vitro
insulin secretion. To delineate androgenic effects of MI-TP administration from potential estrogenic effects attributable to metabolism of applied
androgen to estrogen, TP or the estrogen agonist DES were directly applied to female fetuses (FI-TP/FI-DES) and tissue collected at d90 of gestation.
Genes whose expression was significantly altered in response to MI-TP (Panel A) were analysed (vehicle n = 6, FI-TP n = 7, FI-DES n= 5), in vitro insulin
secretion in response to euglycaemic conditions (5.5 mM glucose) was determined (Panel C) (vehicle n = 5, FI-TP n = 7, FI-DES n= 4). INS, PDX1 and
INSR were significantly elevated by FI-TP (P,0.05), but not FI-DES. As regards IGF1R, there was a trend towards increased expression associated with
FI-TP but not FI-DES (P= 0.06). FI-TP, but not FI-DES was associated with elevated insulin secretion in vitro in response to euglycaemic culture
conditions as compared to in vivo vehicle treated cultures (P,0.05).
doi:10.1371/journal.pone.0056263.g006
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increased insulin synthesis in the absence of effects on b-cell mass
[51,52]. Whilst we were unable to detect expression of ERb by
PCR, we did detect ERa expression in pancreatic tissues (data not
shown). Given prior suggestions that effects of testosterone on fetal
development could potentially be either androgenic in nature or
via metabolism to estrogens [53], experiments to resolve andro-
genic from estrogenic mechanisms of action were conducted.
Direct fetal steroid injection studies demonstrated that the gene
expression effects observed in the MI studies of androgen action
could be replicated by injection of TP into the fetus, but not by
administration of DES. Similarly, in terms of in vitro insulin
secretion, we observed elevated insulin secretion in response to
euglycaemic glucose concentrations in pancreatic cultures derived
from TP treated fetuses as compared to control fetuses, but no
alterations in the DES treated fetal tissue. We therefore ascribe the
effects seen in the MI-TP studies to androgenic stimulation as
opposed to estrogenic effects.
As prenatal androgenization results in a metabolic phenotype
reminiscent of PCOS [4] it is perhaps likely that it shares
developmental similarities with the molecular programming of
PCOS. If this ovine model, and other animal models, inform us
about elements involved in development of PCOS, then it may be
that insulin hypersecretion is an inherent primary feature of PCOS
as previously suggested [3,21]. We therefore propose that prenatal
androgenic stimulation of pancreatic b-cell function/mass regula-
tors may predispose to hyperinsulinemia in response to normal
glucose concentrations in the absence of IR. Subsequently,
compensation in response to developing IR may be altered, and
that this has relevance to human PCOS. In this context it is
fascinating to note suggestions of potential contributions to IR
development made by increased insulin concentrations [24].
In conclusion, we have demonstrated altered development of
the ovine endocrine pancreas in terms of altered expression of
genes which determine b-cell function and mass, altered insulin
secretory response in vitro, and altered b-cell numbers in early
adult life, as a consequence of physiologically relevant androgen
over-exposure in utero. We suggest that b-cell dysfunction may be
distinct from altered pancreatic function in response to insulin
resistance and that its origins reside in fetal life. In addition the
suggestion of ‘male’ and ‘female’ tissues may be of interest in the
context of stem cell biology and transplantation.
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